Data on Promising Chemotherapy for Ovarian Cancer Being Presented Soon

Data on Promising Chemotherapy for Ovarian Cancer Being Presented Soon
DelMar Pharmaceutics and its collaborators at the University of Texas MD Anderson Cancer Center will soon present recent data regarding the activity of  the chemotherapy agent VAL-083 in ovarian cancer models, according to a recent company announcement. The results will be included in a poster, titled “Activity of dianhydrogalactitol (VAL-083) in ovarian tumor models, sensitive or resistant to cisplatin,”

Knowledge is power when living with ovarian cancer.

Get access to the web’s leading Ovarian Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *